Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses - ScienceDirect
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab | SpringerLink
Diagnostic Utility of Complement Serology for Atypical Hemolytic Uremic Syndrome
Correlation of eculizumab serum concentration with blood CH50 and... | Download Scientific Diagram
Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients | PLOS ONE
Frontiers | Expanding Horizons in Complement Analysis and Quality Control
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Frontiers | Interpretation of Serological Complement Biomarkers in Disease
Laboratory diagnosis of complement deficiency. The CH 50 , AH 50 , and... | Download Scientific Diagram
Complement sC5b-9 and CH50 increase the risk of cancer-related mortality in patients with non-small cell lung cancer
Complement sC5b-9 and CH50 increase the risk of cancer-related mortality in patients with non-small cell lung cancer
C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary result
Buy Metosartan CH 50 mg Tablet (10 Tab) Online at Best price in India | Flipkart Health+
Complement Factor 3 Could Be an Independent Risk Factor for Mortality in Patients with HBV Related Acute-on-Chronic Liver Failure
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus - C Magro-Checa, R A Schaarenburg, H J L Beaart, T W J Huizinga, G M Steup-Beekman, L A Trouw, 2016
Used Worth CH50 30" -10 Drop Youth League Bats Youth League Bats
Elevated levels of C3, C4, and CH50 of the complement system in ICU and non‐ICU patients with COVID‐19 - Bagherimoghaddam - 2022 - Health Science Reports - Wiley Online Library
C3:CH50 ratio as a proposed composite marker for Eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary result
Frontiers | Interpretation of Serological Complement Biomarkers in Disease
Frontiers | Complement Activation in Inflammatory Skin Diseases